Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer
T Kamai, T Tsujii, K Arai, K Takagi, H Asami, Y Ito… - Clinical Cancer …, 2003 - AACR
T Kamai, T Tsujii, K Arai, K Takagi, H Asami, Y Ito, H Oshima
Clinical Cancer Research, 2003•AACRPurpose: The small GTP-binding protein Rho and its best-characterized downstream effector
Rho-associated serine-threonine protein kinase, ROCK, participate in actin cytoskeleton
organization, and are linked to pathogenesis and progression of several human tumors. We
investigated the roles of Rho and ROCK in bladder cancer. Experimental Design: Using
Western blotting, we quantitated Rho and ROCK protein expression in paired tumor and
nontumor surgical samples from 107 consecutive Japanese patients with bladder cancer …
Rho-associated serine-threonine protein kinase, ROCK, participate in actin cytoskeleton
organization, and are linked to pathogenesis and progression of several human tumors. We
investigated the roles of Rho and ROCK in bladder cancer. Experimental Design: Using
Western blotting, we quantitated Rho and ROCK protein expression in paired tumor and
nontumor surgical samples from 107 consecutive Japanese patients with bladder cancer …
Abstract
Purpose: The small GTP-binding protein Rho and its best-characterized downstream effector Rho-associated serine-threonine protein kinase, ROCK, participate in actin cytoskeleton organization, and are linked to pathogenesis and progression of several human tumors. We investigated the roles of Rho and ROCK in bladder cancer.
Experimental Design: Using Western blotting, we quantitated Rho and ROCK protein expression in paired tumor and nontumor surgical samples from 107 consecutive Japanese patients with bladder cancer.
Results: RhoA, RhoC, and ROCK were more abundant in tumors and metastatic lymph nodes than in nontumor bladder and uninvolved lymph nodes (P < 0.0001). Amounts of RhoA and RhoC protein, and ROCK protein expression correlated positively with one another (P < 0.0001). High RhoA, RhoC, and ROCK expression were related to poor tumor differentiation (P < 0.05, P < 0.01, and P < 0.01, respectively), muscle invasion (P < 0.001), and lymph node metastasis (P < 0.05). Kaplan-Meier plots linked high RhoA, RhoC, and ROCK protein expression to shortened disease-free and overall survival (P < 0.0001). By univariate analysis, high RhoA, RhoC, and ROCK protein expression predicted shortened disease-free and overall survival (P < 0.0001). By multivariate analysis, only RhoC was independently influenced in disease-free survival (P < 0.05), and RhoA and RhoC in overall survival (P < 0.001). In contrast, RhoB expression was inversely related to the grade and stage (P < 0.05), and its higher expression is associated with better overall survival (P < 0.05). In superficial tumors (Ta or T1; 63 patients), RhoA, RhoC, and ROCK were unrelated with recurrence-free survival. Overall survival in tumors invading muscle (T2 to T4; 44 patients) was significantly influenced by RhoA, RhoC, and ROCK in a Kaplan-Meier analysis (P < 0.0001, P < 0.0001, and P < 0.01, respectively). Whereas RhoA, RhoC, and ROCK independently predicted shortened overall survival in patients with invasive tumor by univariate analysis (P < 0.0001, P < 0.0001, and P < 0.01, respectively), only RhoC did so by multivariate analysis (P < 0.05).
Conclusion: Rho/ROCK pathway apparently involved in occurrence and progression of bladder cancer may be valuable prognostic markers.
AACR
